OnCore Login

Return to Trial Database

HCRN-LUN87-1

A Phase II Trial of VP-16, Ifosfamide and Cisplatin (VIP) Combination Chemotherapy for Previously Untreated Extensive Small Cell Lung Cancer

Status

Study Completed

Cancer Type(s)

Lung

Study Contact

Publications

  • JC Miller, PJ Loehrer, J Songer, K Pennington, R Ansari, S Turner, LH Einhorn
  • AB Sandler, R Ansari, W Fisher, R Gonin, R Levy, LH Einhorn
  • AB Sandler, PJ Loehrer, R Ansari, KW Logie, J Mortimer, R Sridhar, LH Einhorn
  • E Faylona, P Loehrer, L Einhorn, R Ansari, J McClean, S Williams
Daily Oral Etoposide Plus Ifosfamide Plus Cisplatin for Previously Treated Recurrent Small-Cell Lung Cancer
  • EA Faylona, PJ Loehrer, R Ansari, AB Sandler, R Gonin, LH Einhorn
Etoposide Plus Ifosfamide Plus Cisplatin (VIP) in Extensive Small-cell Lung Cancer
  • PJ Loehrer, SM Rynard, R Ansari, J Songer, K Pennington, LH Einhorn
Etoposide, Ifosfamide and Cisplatin (VIP) plus Concurrent Radiation Therapy for Previously Untreated Limited Small Cell Lung Cancer (SCLC): A Phase II study
  • N Hanna, R Ansari, W Fisher, J Shen, S Jung, A Sandler

Trial Locations

All sites in which the trial HCRN-LUN87-1 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278